Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-009941
Filing Date
2023-05-15
Accepted
2023-05-15 17:00:22
Documents
66
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q krbp-20230331x10q.htm   iXBRL 10-Q 1289062
2 EX-31.1 krbp-20230331xex31d1.htm EX-31.1 23257
3 EX-31.2 krbp-20230331xex31d2.htm EX-31.2 19853
4 EX-32.1 krbp-20230331xex32d1.htm EX-32.1 7914
5 EX-32.2 krbp-20230331xex32d2.htm EX-32.2 8040
  Complete submission text file 0001558370-23-009941.txt   5716228

Data Files

Seq Description Document Type Size
6 EX-101.SCH krbp-20230331.xsd EX-101.SCH 39463
7 EX-101.CAL krbp-20230331_cal.xml EX-101.CAL 38597
8 EX-101.DEF krbp-20230331_def.xml EX-101.DEF 171527
9 EX-101.LAB krbp-20230331_lab.xml EX-101.LAB 367142
10 EX-101.PRE krbp-20230331_pre.xml EX-101.PRE 295610
60 EXTRACTED XBRL INSTANCE DOCUMENT krbp-20230331x10q_htm.xml XML 965730
Mailing Address 7707 FANNIN ST. SUITE 140 HOUSTON TX 77054
Business Address 7707 FANNIN ST. SUITE 140 HOUSTON TX 77054 832-968-4888
Kiromic Biopharma, Inc. (Filer) CIK: 0001792581 (see all company filings)

EIN.: 464762913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39619 | Film No.: 23923924
SIC: 2836 Biological Products, (No Diagnostic Substances)